
This fund is not currently rated by our system. However, we continuously review and update our ratings, so it may be included in the future.
எங்கள் score நீண்டகால performance, risk மற்றும் consistency-ஐ மதிப்பிடுகிறது — past returns மட்டும் அல்ல.
13 Nov 2026 நிலவரப்படி
31 Oct 2026 நிலவரப்படி
| Holding | Fund-இன் % | மதிப்பு | பங்குகள் |
|---|---|---|---|
| Marico Ltd. | 4.71% | ₹86.83 Cr | 10,85,344 |
| Laurus Labs Ltd. | 4.50% | ₹82.83 Cr | 3,44,327 |
| Apollo Hospitals Enterprise Ltd. | 4.46% | ₹82.24 Cr | 97,351 |
| Torrent Pharmaceuticals Ltd. | 4.21% | ₹77.66 Cr | 1,68,340 |
| The Federal Bank Ltd. | 4.13% | ₹76.19 Cr | 22,42,815 |
| Grasim Industries Ltd. | 3.79% | ₹69.79 Cr | 2,34,088 |
| Divi's Laboratories Ltd. | 3.54% | ₹65.2 Cr | 66,671 |
| Sun Pharmaceutical Industries Ltd. | 3.50% | ₹64.48 Cr | 3,62,714 |
| Nestle India Ltd. | 3.26% | ₹59.99 Cr | 5,14,085 |
| Hindalco Industries Ltd. | 3.24% | ₹59.69 Cr | 6,74,742 |
Long term Capital Appreciation. Investment in equity and equity related instruments selected based on quant model.
The Scheme seeks to generate long term capital appreciation by investing in equity and equity related securities based on quant model theme. The Scheme does not guarantee/indicate any returns. There is no assurance that the investment objective of the Scheme will be achieved.
Exit load of 0.50%, if redeemed within 90 days.
மியூச்சுவல் ஃபண்டுகள் சந்தை ஆபத்துகளுக்கு உட்பட்டவை. அனைத்து scheme documents-ஐ கவனமாகப் படிக்கவும்.